Yom Chai Signs MOU With Way Of Life Medical Cannabis For Israel, Portugal And Malta.

Yom Chai signs MoU with Way of Life Medical Cannabis

ISRAEL: New medical cannabis company Yom Chai has entered into a Memorandum of Understanding (“MOU”) with Way of Life Medical Cannabis to breed proprietary genetics, formulate, manufacture and distribute a wide range of Cannabis-based products to treat various medical conditions. Yom Chai’s objective is to conduct scientific trials in Israel utilizing various Cannabinoid and Terpene Read the full article…

iCAN Signs MoU With Yom Chai for Crohn’s Disease And Autism

the wide world of weed

ISRAEL: The Directors of Ananda Developments have announced that investee company iCAN has signed an MoU with a new Israeli Medical Cannabis company Yom Chai to develop and clinically validate cannabis based treatments for Crohn’s Disease, Autism and other neurodevelopmental, neurodegenerative and gastrointestinal diseases. Yom Chai has deep experience in the international medical cannabis market Read the full article…

FSD Pharma Inks Saskatchewan Wholesale Supply MOU With High Tide Ventures

FSD PHARMA ENTERS INTO SASKATCHEWAN WHOLESALE SUPPLY MOU OF UP TO 5,000 KILOGRAMS WITH HIGH TIDE VENTURES

CANADA: FSD Pharma this week announced that its wholly-owned subsidiary, FV Pharma Inc. has entered into a non-binding memorandum of understanding with High Tide Ventures Inc. (“High Tide”) dated July 18, 2018 to supply the Saskatchewan market on a wholesale basis with up to 5,000 kilograms of cannabis products over the next year when available. FSD Pharma is Read the full article…